Literature DB >> 31804656

Survival in Oligometastatic Prostate Cancer-A New Dawn or the Will Rogers Phenomenon?

Martin J Connor1, Mathias Winkler1,2, Hashim U Ahmed1,2.   

Abstract

Entities:  

Mesh：

Year:  2020        PMID： 31804656     DOI： 10.1001/jamaoncol.2019.4724

Source DB:  PubMed          Journal:  JAMA Oncol        ISSN： 2374-2437            Impact factor:   31.777


× No keyword cloud information.
  6 in total

1.  Phase II Evaluation of Stereotactic Ablative Radiotherapy (SABR) and Immunity in 11C-Choline-PET/CT-Identified Oligometastatic Castration-Resistant Prostate Cancer.

Authors:  Henan Zhang; Jacob J Orme; Haidong Dong; Sean S Park; Feven Abraha; B J Stish; Val J Lowe; Fabrice Lucien; Erik J Tryggestad; Michael S Bold; Lance C Pagliaro; C Richard Choo; Debra H Brinkmann; Matthew J Iott; Brian J Davis; J Fernando Quevedo; William S Harmsen; Brian A Costello; Geoffrey B Johnson; Mark A Nathan; Kenneth R Olivier; Thomas M Pisansky; Eugene D Kwon
Journal:  Clin Cancer Res       Date:  2021-09-30       Impact factor: 13.801

2.  Diagnostic Age, Age at Death and Stage Migration in Men Dying with or from Prostate Cancer in Denmark.

Authors:  Marc Casper Meineche Andersen; Hein Vincent Stroomberg; Klaus Brasso; John Thomas Helgstrand; Andreas Røder
Journal:  Diagnostics (Basel)       Date:  2022-05-19

Review 3.  Patients with Positive Lymph Nodes after Radical Prostatectomy and Pelvic Lymphadenectomy-Do We Know the Proper Way of Management?

Authors:  Bartosz Małkiewicz; Miłosz Knura; Małgorzata Łątkowska; Maximilian Kobylański; Krystian Nagi; Dawid Janczak; Joanna Chorbińska; Wojciech Krajewski; Jakub Karwacki; Tomasz Szydełko
Journal:  Cancers (Basel)       Date:  2022-05-08       Impact factor: 6.575

4.  Additional Treatments to the Local tumour for metastatic prostate cancer-Assessment of Novel Treatment Algorithms (IP2-ATLANTA): protocol for a multicentre, phase II randomised controlled trial.

Authors:  Martin John Connor; Taimur Tariq Shah; Katarzyna Smigielska; Emily Day; Johanna Sukumar; Francesca Fiorentino; Naveed Sarwar; Michael Gonzalez; Alison Falconer; Natalia Klimowska-Nassar; Martin Evans; Olivia Frances Naismith; Kamalram Thippu Jayaprakash; Derek Price; Shiva Gayadeen; Dolan Basak; Gail Horan; John McGrath; Denise Sheehan; Manal Kumar; Azman Ibrahim; Cathryn Brock; Rachel A Pearson; Nicola Anyamene; Catherine Heath; Iqbal Shergill; Bhavan Rai; Giles Hellawell; Stuart McCracken; Bijan Khoubehi; Stephen Mangar; Vincent Khoo; Tim Dudderidge; John Nicholas Staffurth; Mathias Winkler; Hashim Uddin Ahmed
Journal:  BMJ Open       Date:  2021-02-25       Impact factor: 2.692

Review 5.  Defining Oligometastatic Disease in the New Era of PSMA-PET Imaging for Primary Staging of Prostate Cancer.

Authors:  Samuel J Galgano; Andrew M McDonald; Janelle T West; Soroush Rais-Bahrami
Journal:  Cancers (Basel)       Date:  2022-07-06       Impact factor: 6.575

6.  Cytoreductive prostatectomy improves survival outcomes in patients with oligometastases: a systematic meta-analysis.

Authors:  Yifeng Mao; Mingqiu Hu; Gaowei Yang; Erke Gao; Wangwang Xu
Journal:  World J Surg Oncol       Date:  2022-08-09       Impact factor: 3.253
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.